Philip A. van Damme
Oprichter bij Stichting Sanammad
Actieve functies van Philip A. van Damme
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Stichting Sanammad | Directeur/Bestuurslid | 01-01-2009 | - |
Oprichter | 01-01-2009 | - | |
President | 01-01-2009 | - | |
Sanammad Pharmaceuticals BV | Directeur/Bestuurslid | 01-01-2014 | - |
Oprichter | 01-01-2014 | - | |
President | 01-01-2014 | - |
Loopbaan van Philip A. van Damme
Eerdere bekende functies van Philip A. van Damme
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AXIM BIOTECHNOLOGIES, INC. | Directeur/Bestuurslid | 01-05-2014 | 06-05-2020 |
Hoofd Techniek/Wetenschap/O&O | 01-05-2014 | 06-05-2020 | |
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Directeur/Bestuurslid | 01-01-2012 | - |
Hoofd Techniek/Wetenschap/O&O | 30-07-2013 | - |
Opleiding van Philip A. van Damme
University of Utrecht | Doctorate Degree |
Statistieken
Internationaal
Nederland | 5 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AXIM BIOTECHNOLOGIES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
Stichting Sanammad | Miscellaneous |
Sanammad Pharmaceuticals BV |
- Beurs
- Insiders
- Philip A. van Damme
- Ervaring